Crystal Clinic Orthopaedic Center Surgeon Performs World’s First Meniscus Repair Using Groundbreaking Regenerative Implant Poised to Redefine the Standard of Care
2/6/2025
Fairlawn, Ohio, February 6, 2025 – Paul Fleissner, M.D., a board-certified orthopaedic and pediatric orthopaedic surgeon at Crystal Clinic Orthopaedic Center, and chairman of the board, has performed the world’s first meniscus repair using an innovative, new regenerative implant for meniscal restoration. The procedure treated a college-age athlete who suffered from chronic pain following a prior meniscectomy.
Known as RejuvaKnee™, developed and manufactured by Regenity Biosciences, this collagen-based meniscal implant, which recently received FDA clearance, has been shown in pre-clinical studies to support a more complete recovery by facilitating the regeneration of native meniscal tissue (Source: Reginity Biosciences Data on File 2024).
“Meniscal repair using this groundbreaking regenerative implant represents a real game-changer and a potential new standard of care for meniscal restoration,” said Dr. Fleissner. “It provides an outstanding and most durable solution for patients who have irreparable meniscus tears or have previously lost meniscus tissue.”
Another key advantage of this regenerative implant involves notable reduced wait times for surgery, given it is readily available.
“Extended wait time forces patients to suffer unnecessarily with prolonged pain and the inability to maintain their active lifestyles,” Dr. Fleissner said. “Instead, this new implant is able to fit patients immediately, eliminating long wait times and protracted pain.”
In the coming weeks, Dr. Fleissner will perform several more meniscus repairs using this regenerative implant, which he believes will provide an immediate and long-lasting solution that will improve his patients’ quality of life.
“As Crystal Clinic is a national destination center of excellence, consistently ranked as a Top 100 hospital in America, I am excited to offer this advanced, breakthrough treatment for patients throughout the U.S.,” Dr. Fleissner said.
To learn more or to schedule an appointment online 24/7, visit CrystalClinic.com.
###
About Crystal Clinic Orthopaedic Center
Nationally renowned for orthopaedic care, Crystal Clinic Orthopaedic Center is a physician-owned, orthopaedic specialty hospital system with board-certified/board-eligible surgeons, most with advanced fellowship credentials in their orthopaedic specialty, who collectively perform thousands of surgeries annually. As a national destination center of excellence, Crystal Clinic is a top 100 hospital in America, and is one of just three out of the 6,120 hospitals in the nation to receive The Joint Commission certifications in total hip, total knee, total shoulder, and spinal fusion procedures. Crystal Clinic hospital system is ranked #1 in Ohio and in the top 100 of U.S. hospitals by CareChex/Quantros Analytics’ objective review of all U.S. hospitals and health systems. Crystal Clinic has also earned the nation’s highest five-star rating in patient experience and overall hospital quality from the Centers for Medicare & Medicaid Services, and America’s 100 Best Hospitals for Joint Replacement by Healthgrades. Crystal Clinic is based in Northeast Ohio with 17 clinic, hospital and surgery locations, including several Crystal Clinic QuickCareTM locations that provide immediate, walk-in care for sports and orthopaedic injuries. Crystal Clinic Plastic Surgeons, a division of Crystal Clinic Orthopaedic Center, are experts in treating soft tissue defects related to orthopaedic injuries and provide the entire spectrum of plastic surgery – from reconstruction to cosmetic procedures. Crystal Clinic’s highly advanced, state-of-the-art surgical hospital is the only hospital devoted exclusively to orthopaedics and plastic/reconstructive care.
About Regenity Biosciences
Regenity Biosciences, a Linden Capital Partners portfolio company, is a leading global developer and manufacturer of bioresorbable technologies to repair and regenerate natural tissue and bone for a variety of markets including dental, spine, orthopedic, sports medicine, advanced wound, neurosurgery, ENT, and nerve repair. Founded in 1997, Regenity (formerly Collagen Matrix, Inc.) is headquartered in
Paramus, New Jersey, with manufacturing locations in Oakland and Allendale, New Jersey, and Groningen, the Netherlands. Regenity’s product portfolio includes a variety of collagen-based and synthetic polymer solutions that support the company’s platform for tissue and bone regeneration. Regenity develops proprietary products that are sold to OEM customers on either a contract or private label basis and offers partnership opportunities including contract product development and manufacturing services. For more information, visit regenity.com.